Lixian Zou

928 citations
22 papers · 753 indexed · h-index 11

Lixian Zou

20 papers receiving 747 citations

Peers

Lixian Zou
Comparison fields: 5 of 87
  • Endocrinology, Diabetes and Metabolism 337
  • Cardiology and Cardiovascular Medicine 425
  • Nephrology 62
  • Biochemistry 54
  • Nutrition and Dietetics 90
Replace Brandon A. Kemp with:
Brandon A. Kemp United States
Peter Morsing Sweden
Yukio Ozawa Japan
Kenji Furukawa Japan
Santiago Cuevas United States
Tinatin Chabrashvili United States
M Stuehlinger Austria
H. Dahlheim Germany
Yukako Koura Japan
R. H. Freeman United States
Lixian Zou relative to Brandon A. Kemp United States Brandon A. Kemp's profile →
Citations per field
00.5×3.4×
Brandon A. Kemp · 1×
Citations per year

Countries citing papers authored by Lixian Zou

Since Specialization
Citations

This map shows the geographic impact of Lixian Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lixian Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lixian Zou more than expected).

Fields of papers citing papers by Lixian Zou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lixian Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lixian Zou. The network helps show where Lixian Zou may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Lixian Zou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lixian Zou Line = papers co-authored together Lixian Zou links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20237
3 20220
4 202120
5 20216
6 20192
7 20199
8 20198
9 20193
10 201032
11 200910
12 20098
13 20092
14 200621
15 200569
16 200366
17 199973
18 199739
19 199688
20 1996173

About Lixian Zou

Lixian Zou is a scholar working on Radiology, Nuclear Medicine and Imaging, Endocrinology, Diabetes and Metabolism and Pharmacology, having authored 22 papers that have together received 753 indexed citations. Recurring topics across this work include Advanced MRI Techniques and Applications (7 papers), Hormonal Regulation and Hypertension (5 papers), Renin-Angiotensin System Studies (4 papers), Atomic and Subatomic Physics Research (3 papers), Cardiac Imaging and Diagnostics (3 papers), Sparse and Compressive Sensing Techniques (2 papers), Ion Transport and Channel Regulation (2 papers) and Blood Pressure and Hypertension Studies (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (337 citations), Cardiology and Cardiovascular Medicine (425 citations) and Nephrology (62 citations). Lixian Zou has collaborated with scholars based in United States, China and Switzerland. Frequent co-authors include L. Gabriel Navar, John D. Imig, Anka Hymel, Hidehiko Ono, Annette M. Von Thun, Orson W. Moe, Michel Baum, Kenneth D. Mitchell, I. Alexandru Bobulescu and Vangipuram Dwarakanath. Their work appears in journals such as Kidney International, Hypertension and Journal of the American Society of Nephrology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026